This week we are once again providing an update on the most recent drug shortages noting 73 products as being unavailable. Some of these shortages are short term, or limited availability, while others are completely unavailable with unknown release dates.
The FDA has approved numerous new medications in 2026. Review the latest approvals through June 24, 2026, and discover why staying current is essential for medication reconciliation, survey readiness, and patient safety.
This week we are once again providing an update on the most recent drug shortages noting 76 products as being unavailable. Some of these shortages are short term, or limited availability, while others are completely unavailable with unknown release dates.
This week we are once again providing an update on the most recent drug shortages noting 75 products as being unavailable. Some of these shortages are short term, or limited availability, while others are completely unavailable with unknown release dates.
Another year has flown by. Unbelievably, we are quickly approaching 2026 and it’s time to look back at the biggest topics of 2025.
This week we are once again providing an update on the most recent drug shortages noting 77 products as being unavailable. Some of these shortages are short term, or limited availability, while others are completely unavailable with unknown release dates.
FDA requires opioid manufacturers to update prescribing information
Preview the new medications of 2025, as we reach the halfway point of the year. In this post, we look at the most recent approvals to keep you informed and help you keep your patients safe.
This week we are once again providing an update on the most recent drug shortages.
